{"schema_version":"secwatch.filing_event.v1","accession":"0001193805-26-000916","form_type":"8-K","ticker":"IMUX","cik":"0001280776","company_name":"IMMUNIC, INC.","filed_at":"2026-07-06T20:22:14+00:00","discovered_at":"2026-07-06T20:23:00.331691+00:00","generated_at":"2026-07-06T20:23:13.470406+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Director Tamar Howson resigns; CEO Erik Lundgren appointed to board","bullets":["Tamar Howson resigned from Board and Compensation Committee effective June 29, 2026, due to retirement; no disagreement.","On July 5, 2026, Board appointed CEO Erik Lundgren as Class II director until 2028 annual meeting.","Lundgren will not serve on any board committee and receives no additional compensation for director role.","Lundgren's existing employment agreement with Immunic was previously disclosed (May 27, 2026 8-K)."],"urls":{"canonical":"https://secwatch.observer/filing/0001193805-26-000916","json":"https://secwatch.observer/filing/0001193805-26-000916.json","markdown":"https://secwatch.observer/filing/0001193805-26-000916.md","text":"https://secwatch.observer/filing/0001193805-26-000916.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1280776/000119380526000916/0001193805-26-000916-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1280776/000119380526000916/e665619_8k-immunic.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-06T20:23:13.470406+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}